Litcius/Paper detail

Fatty acid oxidation enzyme Δ3, Δ2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients

Yogesh Bramhecha, Karl‐Philippe Guérard, Étienne Audet‐Walsh, Shaghayegh Rouzbeh, Ola Kassem, Erwan Pernet, Eleonora Scarlata, Lucie Hamel, Fadi Brimo, Maziar Divangahi, Armen Aprikian, Simone Chevalier, Vincent Giguère, Jacques Lapointe

2022Oncogene17 citationsDOI

Topics & Concepts

BiologyProstate cancerCancer researchProstateMetastasisBiochemical recurrenceCancerLNCaPInternal medicineProstatectomyMedicineGeneticsCancer, Lipids, and MetabolismCancer, Hypoxia, and MetabolismPeroxisome Proliferator-Activated Receptors
Fatty acid oxidation enzyme Δ3, Δ2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients | Litcius